Oncology Stakeholders Summit, Spring 2015
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma
4
More Potent and Tolerable, Azenosertib Advances as the Leading WEE1 Inhibitor
5